I

InMode Ltd
D

INMD

18.890
USD
-0.08
(-0.42%)
Market Closed
Volume
43,942
EPS
2
Div Yield
-
P/E
8
Market Cap
1,313,963,276
Related Instruments
    ABBV
    ABBV
    1.200
    (0.60%)
    202.140 USD
    A
    AMWL
    -0.310
    (-2.60%)
    11.630 USD
    A
    ASPS
    -0.06620
    (-8.29%)
    0.73280 USD
    B
    BHC
    0.13500
    (1.88%)
    7.31000 USD
    C
    CUTR
    -0.02430
    (-5.43%)
    0.42320 USD
    E
    ELAN
    -0.120
    (-1.08%)
    11.010 USD
    More
News

Title: InMode Ltd

Sector: Healthcare
Industry: Medical Devices
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medicalaesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.